Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipomatous Hamartoma of the Semilunar Valve Exhibits Molecular Genetic Characteristics of Lipoma.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same authorSame journal

In Reply.

Archives of pathology & laboratory medicine·2026
Same author

GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastases.

Human pathology·2026
Same author

XVIIth Banff Conference on Allograft Pathology: The Banff Workshop heart report on microvascular inflammatory burden in heart transplantation and the impact of molecular and noninvasive diagnostic tools.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Novel BRAF fusion in Erdheim-Chester disease with pulmonary manifestations: Importance of RNA-based testing and response to MEK inhibition.

Histopathology·2026
Same author

Surgical Pathology of Diffuse Parenchymal Lung Disease in Adults With IgA Vasculitis or IgA Nephropathy.

The American journal of surgical pathology·2026
Same journal

Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

Archives of pathology & laboratory medicine·2026
Same journal

Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

Archives of pathology & laboratory medicine·2026
Same journal

Journal Club and Artificial Intelligence.

Archives of pathology & laboratory medicine·2026
Same journal

In Reply.

Archives of pathology & laboratory medicine·2026
Same journal

Using R Statistical Programming to Evaluate the Impact of the Lower Anogenital Squamous Terminology Recommendations on Cervical Biopsy Reporting at a Tertiary Care Academic Center.

Archives of pathology & laboratory medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 15, 2026

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Cardiovascular pseudoneoplasms.

Dylan V Miller1, Henry D Tazelaar

  • 1Mayo Clinic, Rochester, MN 55901, USA. miller.dylan@mayo.edu

Archives of Pathology & Laboratory Medicine
|March 4, 2010
PubMed
Summary
This summary is machine-generated.

Recognizing rare cardiac pseudoneoplasms is crucial for patient care. Distinguishing these benign growths from tumors prevents unnecessary and harmful treatments, improving outcomes.

Related Experiment Videos

Last Updated: Jun 15, 2026

A Patient-Derived Xenograft Model for Venous Malformation
06:51

A Patient-Derived Xenograft Model for Venous Malformation

Published on: June 15, 2020

Area of Science:

  • Cardiovascular Pathology
  • Oncology
  • Histopathology

Background:

  • Primary cardiac tumors are rare, with most being benign neoplasms.
  • Mass-forming reactive and pseudoneoplastic growths are less common but critical to identify.
  • Accurate differentiation of these lesions from neoplasms is vital for patient management.

Purpose of the Study:

  • To discuss the clinical, imaging, gross pathologic, and histologic features of five key cardiac pseudoneoplasms.
  • To emphasize features that differentiate these pseudoneoplasms from other cardiac tumors.
  • To guide appropriate patient care by distinguishing benign lesions from neoplastic growths.

Main Methods:

  • Review of pertinent literature citations.
  • Analysis of authors' observational experience with cardiac lesions.
  • Synthesis of clinical, imaging, and pathologic data.

Main Results:

  • Detailed description of inflammatory myofibroblastic tumor, hamartoma, mesothelial/monocytic cardiac excrescences, calcified amorphous tumor, and lipomatous hypertrophy.
  • Identification of key differentiating features for each pseudoneoplasm.
  • Emphasis on the importance of accurate diagnosis for therapeutic decisions.

Conclusions:

  • Cardiac pseudoneoplasms, while lacking malignant potential, can cause significant morbidity and mortality.
  • Recognition is essential for guiding appropriate patient management and therapy.
  • Accurate diagnosis avoids inappropriately aggressive and toxic treatments.